Guidelines for the Surgical Management of Pancreatic Adenocarcinoma

Seminars in Oncology

Volumn 34, Issue 4, 2007, Pages 311-320

  Ujiki, Michael B ^a   Talamonti, Mark S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT OBSTRUCTION; BYPASS SURGERY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC IMAGING; HUMAN; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MORBIDITY; MORTALITY; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; RADIODIAGNOSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TERTIARY HEALTH CARE;

ADENOCARCINOMA; ANASTOMOSIS, SURGICAL; GUIDELINES; HUMANS; LYMPH NODE EXCISION; MESENTERIC VEINS; PALLIATIVE CARE; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; PYLORUS; SURVIVAL ANALYSIS;

EID: 34547438258     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.05.004     Document Type: Article

References (100)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Brunschwig A. A one-stage pancreaticoduodenectomy. Surg Gynecol Obstet 65 (1937) 681-684
3. Halsted W. Contributions to the surgery of the bile passages, especially the common bile duct. Boston Med Surg J 141 (1899) 645-654
4. Whipple A., Parson W., and Mullins C. Treatment of carcinoma of the ampulla of Vater. Ann Surg 102 (1935) 763-779
5. Crile G. The advantages of bypass operations over radical pancreaticoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 130 (1970) 1049-1053
6. Shapiro T.M. Adenocarcinoma of the pancreas: A statistical analysis of biliary bypass vs. Whipple resection in good risk patients. Ann Surg 182 (1975) 715-721
7. Crist D., Sitzman J., and Cameron J. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 206 (1987) 358-365
8. Trede M., Schwall G., and Saeger H. Survival after pancreaticoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 211 (1990) 447-458
9. Sener S.F., Fremgen A., Menck H.R., et al. Pancreatic cancer: A report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the national cancer database. J Am Coll Surg 189 (1999) 1-7
10. Alexakis N., Halloran C., Raraty M., et al. Current standards of surgery for pancreatic cancer. Br J Surg 91 (2004) 1410-1427
11. McCarthy M.J., Evans J., Sagar G., et al. Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg 85 (1998) 320-325
12. Chong M., Freeny P.C., and Schmiedl U.P. Pancreatic arterial anatomy: Depiction with dual-phase helical CT. Radiology 208 (1998) 537-542
13. Vedantham S., Lu D.S., Reber H.A., and Kadell B. Small peripancreatic veins: Improved assessment in pancreatic cancer patients using thin-section pancreatic phase helical CT. Am J Roentgenol 170 (1998) 377-383
14. Roche C.J., Hughes M.L., Garvey C.J., et al. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. Am J Roentgenol 180 (2003) 475-480
15. Gulliver D., Baker M., and Cheng C. Malignant biliary obstruction: efficacy of thin-sction dynamic CT in determining resectability. Am J Roentgenol 159 (1992) 503-507
16. Freeny P., Traverso L., and Ryan J. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg 165 (1993) 600-606
17. Fuhrman G., Charnsangavej C., and Abbruzzese J. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 167 (1994) 104-113
18. Wayne J.D., Abdalla E.K., Wolff R.A., et al. Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation. Oncologist 7 (2002) 34-45
19. Ichikawa T., Haradome H., Hachiya J., et al. Pancreatic ductal adenocarcinoma: Preoperative assessment with helical CT versus dynamic MR imaging. Radiology 202 (1997) 655-662
20. Megibow A.J., Zhou X.H., Rotterdam H., et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability-report of the Radiology Diagnostic Oncology Group. Radiology 195 (1995) 327-332
21. Varadhachary G.R., Tamm E.P., Abbruzzese J.L., et al. Borderline resectable pancreatic cancer: Definitions, management, and role of preoperative therapy. Ann Surg Oncol 13 (2006) 1035-1046
22. 18F-fluorodeoxyglucose: diagnostic limitations. World J Surg 24 (2000) 1121-1129
23. Shreve P.D. Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease. Eur J Nucl Med 25 (1998) 259-264
24. Diederichs C.G., Staib L., and Glatting G. FDG PET: Elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 39 (1998) 1030-1033
25. Rosch T., Lightdale C., Botet J.F., et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 326 (1992) 1721-1726
26. Rosch T., Dittler H.J., Strobel K., et al. Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: A blind reevaluation of the videotapes. Gastrointest Endosc 52 (2000) 469-474
27. Rosch T. Staging of pancreatic cancer: Analysis of literature results. Gastrointest Endosc Clin N Am 5 (1995) 735-739
28. Raut C.P., Grau A.M., Staerkel G.A., et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 7 (2003) 118-126
29. Stewart C.J., Mills P.R., Carter R., et al. Brush cytology in the assessment of pancreatico-biliary strictures: A review of 406 cases. J Clin Pathol 54 (2001) 449-455
30. Tanaka M. Intraductal papillary mucinous neoplasm of the pancreas. Pancreas 28 (2004) 282-288
31. Povoski S.P., Karpeh M.S., Conlon K.C., et al. Association of preoperative biliary drainage with postoperative outcome following pancreatoduodenectomy. Ann Surg 230 (1999) 131-142
32. Pisters P.W., Hudec W.A., Hess K.R., et al. Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 234 (2001) 47-55
33. Sewnath M., Birjmohun R., Rauws E., et al. The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J Am Coll Surg 192 (2001) 726-734
34. Sohn T.A., Yeo C.J., Cameron J.L., et al. Do preoperative biliary stents increase postpancreaticoduodenectomy complications?. J Gastrointest Surg 4 (2000) 258-268
35. Ritts R.E., and Pitt H.A. CA 19-9 in pancreatic cancer. Surg Oncol Clin N Am 7 (1998) 93-101
36. Forsmark C.E., Lambiase L., and Vogel S.B. Diagnosis of pancreatic cancer and prediction of unresectability using the tumor-associated antigen CA 19-9. Pancreas 9 (1994) 731-734
37. Ritts R.E., Nagorney D.M., and Jacobsen D.J. Comparison of preoperative serum CA 19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic or gallbladder disease. Pancreas 9 (1994) 707-716
38. Schlieman M.G., Ho H.S., and Bold R.J. Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg 138 (2003) 951-956
39. Katz A., Hanlon A., and Lanciano R. Prognostic value of CA 19-9 levels in patients with carcinoma of the pancreas treated with radiotherapy. Int J Radiat Oncol Biol Phys 41 (1998) 393-396
40. Warshaw A.L., Gu Z.Y., and Wittenberg J. Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 125 (1990) 230-233
41. Warshaw A.L., Tepper J.E., and Shipley W.U. Laparoscopy in the staging and planning of therapy in pancreatic cancer. Am J Surg 151 (1986) 76-80
42. Conlon K.C., Dougherty E., and Klimstra D.S. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg 223 (1996) 134-140
43. Friess H., Kleff J., and Silva J.C. The role of diagnostic laparoscopy in pancreatic and periampullary malignancies. J Am Coll Surg 186 (1998) 675-682
44. Barreiro C.J., Lillemoe K.D., and Konairis L.G. Diagnostic laparoscopy for periampullary and pancreatic cancer: What is the true benefit?. J Gastrointest Surg 6 (2002) 75-81
45. Pisters P.W., Lee J.E., and Vauthey J.N. Laparoscopy in the staging of pancreatic cancer. Br J Surg 88 (2001) 325-337
46. Jimenez R.E., Warshaw A.L., and Rattner D.W. Impact of laparoscopic staging in the treatment of pancreatic cancer. Arch Surg 135 (2000) 409-415
47. Nieveen Van Dijkum E.J., Romijn M.G., and Terwee C.B. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg 237 (2003) 66-73
48. Montgomery R.C., Hoffman J.P., and Riley L.B. Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas. Ann Surg Oncol 4 (1997) 551-556
49. John T.G., Greig J.D., Carter D.C., and Garden O.J. Carcinoma of the pancreatic head and periampullary region: tumor staging with laparoscopy and laparoscopic ultrasonography. Ann Surg 221 (1995) 156-164
50. Evans D.B., Pisters P.W.T., and Lee J.E. Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer. In: Baker R.J., and Fischer J.E. (Eds). Mastery of Surgery (2001), Lippincott Williams & Wilkins, New York, NY 1299-1318
51. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: Randomized control trial evaluating survival, morbidity, and mortality. Ann Surg 236 (2002) 355-368
52. Riall T.S., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-Part 3: Update on 5-year survival. J Gastrointest Surg 9 (2005) 1191-1206
53. Pedrazzoli P., DiCarlo V., Dionigi R., et al. Standard versus extended lymphadenectomy associated with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Ann Surg 228 (1998) 508-517
54. Bold R.J., Charnsangavej C., and Cleary K.R. Major vascular resection as part of pancreaticoduodenectomy for cancer: Radiologic, intraoperative, and pathologic analysis. J Gastrointest Surg 3 (1999) 233-243
55. Bachellier P., Nakano H., Oussoultzoglou P.D., et al. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?. Am J Surg 182 (2001) 120-129
56. Sasson A.R., Hoffman J.P., Ross E.A., et al. En bloc resection for locally advanced cancer of the pancreas: Is it worthwhile?. J Gastrointest Surg 6 (2002) 147-158
57. Nakagohri T., Kinoshita T., Konishi M., et al. Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 186 (2003) 149-153
58. van Genen R.C., ten Kate F.J., de Wit L.T., et al. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 129 (2001) 158-163
59. Harrison L.E., and Brennan M.F. Portal vein resection for pancreatic adenocarcinoma. Surg Oncol Clin N Am 7 (1998) 165-181
60. Talamonti M.S., Small W., Mulcahy M.F., et al. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol 13 (2006) 1-9
61. Lin P.W., and Lin Y.J. Prospective randomized comparison between pylorus-preserving and standard pancreatoduodenectomy. Br J Surg 86 (1999) 603-607
62. Tran K., Smeenk H., van Eijck C., and Kazmeir J. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: A randomized, multicenter stuffy of 170 patients with pancreatic or periampullary tumors. Ann Surg 240 (2004) 738-745
63. Lerut J.P., Gianello P.R., Otte J.B., and Kestens P.J. Pancreaticoduodenal resection: Surgical experience and evaluation of risk factors in 103 patients. Ann Surg 199 (1984) 432-437
64. Hertner F.P., Cooperman A.M., Ahlborn T.N., et al. Surgical experience with pancreatic and periampullary cancer. Ann Surg 195 (1982) 274-281
65. Aston S.J., and Longmire W.P. Pancreaticoduodenal resection: twenty years experience. Arch Surg 106 (1973) 813-817
66. Schlitt H.J., Schmidt U., Simunec D., et al. Morbidity and mortality associated with pancreatogastrostomy and pancreatojejunostomy following partial pancreatoduodenectomy. Br J Surg 89 (2002) 1245-1251
67. Yeo C.J., Cameron J.L., Maher M.M., et al. A prospective trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222 (1995) 580-588
68. Sikora S., and Posner M. Management of the pancreatic stump following pancreaticoduodenectomy. Br J Surg 82 (1995) 1590-1597
69. Bassi C., Falconi M., Molinari E., et al. Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: Results of a prospective randomized trial. Surgery 134 (2003) 766-771
70. Balcom J.H., Rattner D.W., Warshaw A.L., et al. Ten-year experience with 733 pancreatic resections: Changing indications, older patients, and decreasing length of hospitalization. Arch Surg 136 (2001) 391-398
71. Bassi C., Falconi M., Salvia R., et al. Role of octreotide in the treatment of external pancreatic pure fistulas: A single-institution prospective experience. Arch Surg 385 (2000) 10-13
72. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 232 (2000) 419-429
73. Lowy A.M., Lee J.E., Pisters P.W., et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226 (1997) 632-641
74. Ohtsuka T., Yamaguchi K., Chijiiwa K., et al. Postoperative pancreatic exocrine function influences body weight maintenance after pylorus-preserving pancreatoduodenectomy. Am J Surg 182 (2001) 524-529
75. Lillemoe K.D., Cameron J.L., Hardcare J.M., et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer?. A prospective randomized trial 230 (1999) 322-330
76. Birkmeyer J.D., Warshaw A.L., Finlayson S.R., et al. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 126 (1999) 178-183
77. Delcore R., Rodriguez F.J., Forster J., et al. Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection. Am J Surg 172 (1996) 463-468
78. Richter A., Niedergethmann M., Sturm J.W., et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27 (2003) 324-329
79. Yeo C.J., Cameron J.L., Sohn T.A., et al. Six hundred and fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg 226 (1997) 248-260
80. Gouma D.J., van Geenen R.C., van Gulik T.M., et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume: Toward the end of completion pancreatectomy. Ann Surg 232 (2000) 786-795
81. Buchler M.W., Wagner M., Schmied B.M., et al. Changes in morbidity after pancreatic resection. Arch Surg 138 (2003) 1310-1314
82. Bottger T.C., and Junginger T. Factors influencing morbidity and mortality after pancreaticoduodenectomy: Critical analysis of 221 resections. World J Surg 23 (1999) 164-172
83. Cunningham J.D., Weyant M.T., Levitt M., et al. Complications requiring reoperations following pancreatectomy. Int J Pancreatol 24 (1998) 23-29
84. Farley D.R., Schwall G., and Trede M. Completion pancreatectomy for surgical complications after pancreatoduodenectomy. Br J Surg 83 (1996) 176-179
85. Halloran C.M., Ghaneh P., Bosonnet L., et al. Complications of pancreatic cancer resection. Dig Surg 19 (2002) 138-146
86. Rosemurgy A.S., Bloomston M., and Serfini F.M. Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality. J Gastrointest Surg 5 (2001) 21-26
87. Zervos E.E., Rosemurgy A.S., Al-Saif O., et al. Surgical management of early-stage pancreatic cancer. Cancer Control 11 (2004) 23-31
88. Yeo C.J., Barry M.K., Sauter P.K., et al. Erythromycin accelerates gastric emptying after pancreatoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg 218 (1993) 229-238
89. Bakkevold K.E., and Kmbstad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery: Risk factors influencing the short-term results. Ann Surg 217 (1993) 356-368
90. Buchler M.W., Friess H., Wagner M., et al. Pancreatic fistula after pancreatic head resection. Br J Surg 87 (2000) 883-889
91. Conlon K.C., Labow D., Leung D., et al. Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg 234 (2001) 487-493
92. Cullen J.J., Sarr M.G., and Ilstrup D.M. Pancreatic anastomotic leak after pancreaticoduodenectomy: Incidence, significance, and management. Am J Surg 168 (1994) 295-298
93. van Berge Henegouwen M.I., de Witt L.T., van Gulik T.M., et al. Incidence, risk factors, and treatment of pancreatic leakage after pancreatoduodenectomy: Drainage versus resection of pancreatic remnant. J Am Coll Surg 185 (1997) 18-25
94. Sohn T.A., Yeo C.J., Cameron J.L., et al. Pancreaticoduodenectomy: role of interventional radiologists in managing patients and complications. J Gastrointest Surg 7 (2003) 209-219
95. Rumstadt B., Schwab M., Korth P., et al. Hemorrhage after pancreatoduodenectomy. Ann Surg 227 (1998) 236-241
96. Allma J.H., Reinders M.E., van Gulik T.M., et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 75 (1995) 2069-2076
97. Yeo C.J., Sohn T.A., Cameron J.L., et al. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227 (1998) 821-831
98. Luttges J., Vogel I., Menke M., et al. The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 433 (1998) 237-242
99. Karpoff H.M., Klimstra D.S., Brennan M.F., et al. Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 136 (2001) 44-47
100. Ihse I., Anderson H., and Andren-Sandberg A. Total pancreatectomy for cancer of the pancreas: Is it appropriate?. World J Surg 20 (1996) 288-294